Description:

The Donald L. Levin MD Lectureship  

presenting at 8:00am

Mechanisms of Pathogenesis of Chronic Sinus Disease
Robert P Schleimer, PhD

Chief of Allergy and Immunology in the Department of Medicine, Roy and Elaine Patterson Professor of Medicine
Professor of Medicine (Allergy and Immunology), Microbiology-Immunology and Otolaryngology - Head and Neck Surgery
Northwestern University Feinberg School of Medicine
******************************
presenting at 10:45 am

Atopic Dermatitis: Unleashing the Power of Translational Medicine
Lisa A. Beck, MD

Deans Professor of Dermatology, Medicine and Pathology
University of Rochester Medical Center
Presenting: TBA

Course Objectives:

At the conclusion of this activity, participants should be able to:

1. Discuss new technology used in addressing dermatologic problems.
2. Understand the choices and risks for treating skin disease.
3. Discuss the ethical issues that arise in patient care.
4. Recognize the relevance of new laboratory discoveries to clinical issues.

Accreditation Statement:
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement:
Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Course Director Disclosure: Amy S. Paller, MD, MS has disclosed the following relevant financial relationships:
Serves as a consultant (with honoraria) for the following companies: AbbVie, Anacor Pharmaceuticals, Inc., Celgene Corporation, Chugai Pharma, Galderma Laboratories, L.P. LEO Pharma US, Novartis Pharmaceuticals Corp., Onset Dermatologics, Promius Pharma, LLC. Scioderm, Shire, and Stiefel a GSK company.
Serves as a Principal Investigator (no honoraria) for the following companies: Amgen, Anacor Pharmaceuticals, Inc., Scioderm, and TopMD.

FSM’s CME leadership and staff have nothing to disclose:
Clara J. Schroedl, MD, Medical Director of CME, Sheryl Corey, Manager of CME, Jen Banys, Senior Program Administrator, Allison McCollum, Senior Program Coordinator, and Rhea Alexis Banks, Administrative Assistant 2.

Disclosure(s):
Robert P. Schleimer, PhD discloses the following:
Research grant
National Institutes of Health
Serves as a consultant with the following
ActoBio Therapeutics
Lyra Therapeutics
Allakos
Sanofi-Aventis
Genentech, Inc.
Serves as a consultant with stock options (not yet valued)
Aqualung Therapeutics Corp
BioMarck
Exicure Inc

Lisa A Beck, MD discloses the following information:
Has contracted research with the following
Abbvie
Pfizer, Inc.
Leo Pharma
Regeneron
Serves as a consultant with the following
Abbvie
AstraZeneca
Lilly
Novartis AG
Regeneron
Leo Pharma
Sanofi-Aventis